The Food and Drug Administration (FDA) inspected Parkland Health and Hospital Services System in Dallas on April 9, reviewing blood and blood products, the FDA’s website shows.
The inspection concluded with no corrective actions recommended for the organization’s management operations.
Across the country, the FDA regularly inspects facilities to confirm workplace conditions and product compliance with FDA-regulated laws and regulations to advance the nation’s public health. Inspection outcomes are then made public.
As noted on its website, the FDA is a federal agency in charge of overseeing the safety and quality of human and animal drugs, biological products, medical devices and tobacco products.
Information for this report came from the U.S. Food and Drug Administration. Access the original data here.
